AMGEN Inc

NASDAQ: AMGN
$282.87
+$2.80 (+1.0%)
Closing Price on November 29, 2024

AMGN Articles

24/7 Wall St. loves companies which send capital back to shareholders via dividends.  With all of the uncertainty in today’s markets and in the fluctuating economy, having a solid dividend policy...
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments.  The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set to take...
When we issued our earnings previews for the week ahead, it looked as though Dendreon Corporation (NASDAQ: DNDN) had a chance of really setting the trend for the entire biotech sector this week. ...
Earnings season is in full swing and we have many key reports due in the coming week.  24/7 Wall St. has provided some detailed previews for the key earnings reports we expect to show in detail on...
AuthorDendreon Corp. (NASDAQ: DNDN), maker of prostate cancer drug Provenge, is once again rumored to be a takeover target. As Streetinsider.com points out, the company’s new chairman presided over...
You might have already heard the reports that Apple is sitting on a lot of cash, around the $100 billion mark. You might have even read the scores of recommendations about what it should do with all...
The three major US equities indexes opened sharply lower this morning and the slide continued pretty much without interruption all day. About half an hour before closing, all three indexes are down...
Jon OggThese are some of this Tuesday’s top analyst upgrades, downgrades, and initiations seen in Wall Street research calls. Amgen Inc. (NASDAQ: AMGN) Cut to Market Perform at Bernstein....
The three major US stock indexes opened a bit higher this morning, and after some volatility have managed to get to the final half hour of trading with a modest gain. Some news is leaking out about...
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Thursday morning. Amgen Inc. (NASDAQ: AMGN) Cut to Perform at...
All three major indexes opened higher this morning, but the strength didn’t last as the Chicago PMI number failed to meet expectations and came in lower even than last month’s reading. The lower...
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) Reiterated Buy and...